The complex world of clinical trials just got a new AI-powered ally. Risklick, a startup developing software to reinvent clinical trial protocol development, has secured $100K in seed funding.
The company's Protocol AI is described as a first-in-class solution, specifically designed to empower experts. By streamlining the often-cumbersome process of developing clinical trial protocols, Risklick aims to enable faster, cheaper, and safer trials, ultimately paving the way for quicker medical innovation.















